Legend Star, founded in 2008 and based in Beijing, China, is a venture capital firm that focuses on fostering entrepreneurship through investments and support initiatives. As the independent early-stage investment arm of Legend Holdings, which is known for its diverse portfolio including Lenovo and other prominent companies, Legend Star has been instrumental in incubating and investing in nearly 600 startups. The firm primarily targets investments in cutting-edge technology and medical health sectors, while also exploring other innovative fields. In addition to financial backing, Legend Star provides valuable resources such as CEO training sessions and facilitates an entrepreneurs alliance, contributing to the growth and development of the Chinese entrepreneurial ecosystem.
X-ORIGIN is an intelligent robot developer focused on creating AI companion robots for a variety of applications. Its technical architecture emphasizes the integration of terminal control and massive language models, with the goal of providing a personalized interactive experience and creating more consumer-grade products based on self-developed AI models.
Deepin Technology
Seed Round in 2025
Deepin Technology is a company that utilizes artificial intelligence, quantum chemistry, and high-throughput experiment technologies to enhance the efficiency and workflow of chemical material innovation. it offers efficient R&D solutions for chemical materials, aiming to solve lab bottlenecks, promote innovative research, and enhance customer value.
BlueSky Aviation
Angel Round in 2025
BlueSky Aviation focused on the research and development and manufacturing of large-scale extended-range tilt-rotor eVTOL aircraft.
Primus Labs
Seed Round in 2025
Primus connects Web2 data to Web3, offering verified information to AI models while ensuring user privacy.
Ubot Robotics
Venture Round in 2024
Ubot Robotics is dedicated to developing leg-and-foot bionic robots and has built a diverse range of bipedal, quadrupedal, hexapodal, and other leg-and-foot bionic robots.
CytoTronics
Seed Round in 2024
CytoTronics specializes in the design and development of advanced cell culture plates that incorporate high-density electronic systems. Its semiconductor-based technology facilitates the visualization of live cell functions at scale, providing researchers with real-time data on cellular behavior. This capability enhances the study of complex biological processes, which may lead to significant advancements in drug discovery and personalized medicine. By enabling a deeper understanding of cell biology, CytoTronics aims to support innovative research and foster breakthroughs in various scientific fields.
Pharos
Seed Round in 2024
Pharos incorporates effective blockchain technology into real-world asset verticals and decentralized finance. Pharos Network is promoting trustless innovations that benefit asset markets and underprivileged communities, bolstering the global economy of the future and facilitating the widespread use of Web3 technologies.
Healingovation
Seed Round in 2024
Healingovation is a med-tech company that specializes in the development and manufacturing of surgical robots, intelligent diagnosis and treatment equipment.
Arnatar Therapeutics
Series A in 2024
Arnatar Therapeutics is a biopharmaceutical company that specializes in the development of novel nucleic acid medications.
X Square
Seed Round in 2024
X Square is a company focused on developing universal embodied large models for robots, aiming to create a universal brain-cerebellum system that offers comprehensive capabilities from perception to action.
ENSEM Therapeutics
Series A in 2023
ENSEM Therapeutics is an innovative drug discovery and development company focused on creating precision medicines for oncology. Utilizing its Kinetic Ensemble platform, the company aims to discover and develop transformative small-molecule therapies that address complex drug targets associated with cancer. By integrating advanced technologies, ENSEM Therapeutics can detect and characterize rare conformational states in drug targets, which are crucial for understanding oncogenic processes, regulatory mechanisms, and drug resistance. This approach opens new avenues for therapeutic intervention, allowing drug developers to target high-value and challenging areas within oncology while also considering potential applications in genetic disorders and other diseases.
Carbon Energy Technology
Series A in 2023
Carbon Energy Technology specializes in the development of innovative solutions for carbon utilization and commercialization. The company focuses on transforming carbon emissions into valuable compounds, including formic acid, isobutanol, and syngas. This technology allows businesses to repurpose waste emissions, thereby reducing their environmental impact and supporting efforts toward carbon neutrality. By providing economically viable alternatives, Carbon Energy Technology helps its clients improve sustainability and operational efficiency while addressing the challenges associated with carbon emissions.
CoJourney
Series A in 2023
CoJourney is a CDMO platform for gene therapy that combines plasmid, viral vector, and mRNA generation, analysis, and detection.
China Reserve National Energy
Series A in 2023
China Reserve National Energy is a developer of air energy storage technology. This technology has the advantages of large scale, low cost, long life, clean and pollution-free, unlimited energy storage period, independent of fossil fuels and geographical conditions, etc.
Rgenta Therapeutics
Series A in 2022
Rgenta Therapeutics, Inc. is a biopharmaceutical company based in Cambridge, Massachusetts, specializing in the development of RNA-targeting medicines with a primary focus on oncology and neurological disorders. Founded in 2018, the company utilizes a proprietary platform that analyzes extensive genomic data to identify targetable RNA processing events. This platform enables the design of small-molecule compounds that modulate interactions among the spliceosome, regulatory proteins, and RNAs. By unlocking the therapeutic potential of previously undruggable targets, Rgenta aims to create oral, small-molecule therapies that address critical needs in human disease treatment, particularly in the realm of cancer.
Juexin Technology
Seed Round in 2022
Juexin Technology is an entity that designs high-speed optoelectronic chips. Its primary focus is on the development of electrical chips for high-speed optical communications.
CiDi
Series C in 2022
CiDi focuses on the technological innovation and execution required to create practical, self-driving commercial vehicles and products. The company has obtained public road testing permits for SAE Level 4 trucks capable of exceeding 100km/h on highways. During the first two years, the company completed numerous projects for various commercial and special vehicles. CiDi, for example, has delivered unmanned and remote-controlled mining trucks to mining areas for operation, as well as operated intelligent buses on open city streets and mass-produced V2X-connected vehicles and equipment in multiple cities and regions.
J-Elephant
Angel Round in 2022
J-Elephant specializes in the development of intelligent mobile robots and industrial automation products, particularly focusing on autonomous mobile robots (AMR) tailored for the manufacturing sector. The company's flagship offering is a forklift AMR, which aims to enhance internal logistics by providing flexible solutions for manufacturers. Through its innovative technology, J-Elephant addresses the evolving needs of the manufacturing industry, facilitating improved efficiency and productivity in material handling and logistics operations.
Aden Technology
Series B in 2022
Aden Technology, founded in 2016, specializes in the application of artificial intelligence and big data analytics within the medical sector. The company focuses on enhancing disease classification and improving the quality of medical records. It serves nearly 4,000 secondary and tertiary public hospitals and other healthcare institutions by offering solutions based on Diagnosis-Related Groups (DRG) and Diagnosis-Intervention Packages (DIP). These solutions are designed to evaluate medical service efficiency, facilitate medical insurance payments, support cost accounting, and optimize performance distribution. Aden Technology’s core technology centers around nosology, enabling better disease classification through advanced data mining techniques, ultimately aiming to improve operational efficiency in medical institutions.
Tensor Security
Seed Round in 2022
Tensor Security is a full-stack endogenous cloud-native security solution. Their solution includes automation and devsecops,safety compliance, market container security,dynamic privileged account management, and cloud host security. Their cloud-native security platform builds a trusted image security system to ensure image security throughout the entire life cycle of cloud-native applications.
Palline Data
Series A in 2022
Palline is a company that specializes in hospital management solutions and operational data analysis. It leverages data to encourage hospital management to implement lean practices and enhance the allocation of medical resources through strategic adjustments. By employing statistical methods and artificial intelligence, Palline develops mathematical models for performance evaluation and incentive system construction. This enables hospital operators to conduct strategy analysis and quantitative evaluations more efficiently. The company offers comprehensive solutions that encompass management concepts, tools, big data applications, and software systems, all aimed at optimizing hospital operations and resource allocation.
Blue Elephant Zhilian
Series A in 2022
Blue Elephant Zhilian is a developer of a financial privacy computing platform. The company's platform are licensed under the Ministry of Industry and Information Technology and Ministry of Public Security of China.
Redbud Medicine
Seed Round in 2022
Redbud Medicine specializes in providing clinical trial services tailored for the pharmaceutical and biotechnology sectors. The company is dedicated to optimizing and accelerating clinical development processes, which helps clients reduce operational costs and expedite studies. By focusing on real-time data analysis during innovation and trials, Redbud Medicine supports both local Chinese biotechnology firms in navigating the global market and foreign biotechnology companies seeking to introduce their products in China. Through its innovative and efficient services, Redbud Medicine facilitates the advancement of biotechnological innovations on an international scale.
Axera
Series A in 2022
Axera is a high-tech semiconductor company that specializes in creating advanced artificial intelligence system-on-chips (SoCs) for various computer applications. The company's innovative chips are designed to excel in visual processing, delivering high performance while maintaining low power consumption and low latency. Axera's technology enables real-time video analysis, high-quality video capture, and efficient integration of multiple cameras, all at a competitive cost. This focus on high-integration architecture positions Axera as a key player in the semiconductor industry, catering to clients seeking efficient and effective solutions for complex visual tasks.
IBT Wujiang Technology
Seed Round in 2021
IBT Wujiang Technology is a med-tech firm focusing on the use of digital therapy for the screening and treatment of cranial nerve diseases. It has promoted the development of multiple cranial nerve diseases diagnosis and treatment product pipelines, involving children with ADHD, autism, and stroke. The treatment of multiple indications such as post-cognitive impairment and schizophrenic cognitive impairment has been improved.
Cargene
Seed Round in 2021
Founded in 2020, Cargene Biopharma is a preclinical-stage biopharmaceutical company developing innovative oligonucleotide therapeutics for liver fibrosis and ophthalmic disorders, with operations in Singapore, USA and China. Cargene uses proprietary platforms backed by novel biology and chemistry insights, Cargene aims to improve quality of life for millions of patients worldwide through creating highly specific, stable and potent nucleic acid-based medicines for the treatment of a broad range of diseases.
Carcell BioPharma
Seed Round in 2021
Carcell Biopharma is a pre-clinical biotechnology company focused on the development of innovative cell and gene therapy products. The company specializes in engineered red blood cells aimed at immune regulation and employs non-viral vector gene delivery systems based on lipid nanoparticles. By utilizing a unique cross-border business model, Carcell Biopharma is dedicated to accelerating the discovery and development of next-generation therapies, positioning itself at the forefront of biopharmaceutical advancements.
Merico
Series A in 2021
Merico Inc. is a technology company that specializes in code contribution analytics, offering a platform designed to help software companies track and analyze their code repositories. Founded in 2018 and headquartered in San Francisco, California, Merico serves executives, management, and developers by utilizing advanced program analysis and machine learning. The company's solutions enable engineering teams to gain insights into productivity and code quality, facilitating better resource allocation and enhanced team performance. Through its innovative analytics technology, Merico aims to support organizations in optimizing their software development processes and improving overall efficiency.
HAI ROBOTICS
Series D in 2021
HAI ROBOTICS, founded in 2016 and based in Shenzhen, China, specializes in autonomous case-handling robotic systems for warehouse automation. The company offers a variety of intelligent solutions, including a goods-to-person system, smart in-plant logistics solutions for manufacturing, and multi-tier steel platforms for diverse applications. As a pioneer in the field, HAI ROBOTICS launched its first autonomous case-handling robot, HAIPICK, in 2015, and has since focused on research and development, securing numerous patents. The HAIPICK system significantly enhances warehouse efficiency, reportedly increasing operational productivity by three to four times and boosting storage density by 80% to 130%. HAI ROBOTICS caters to a broad range of clients, including major logistics and supply chain companies, and is committed to delivering flexible and customizable automation solutions to optimize warehouse operations.
Minayo
Series A in 2021
Minayo is a food company specializing in the manufacture and distribution of health supplements and functional snacks. The company aims to enhance consumer health and performance by offering products that are both nutritious and convenient. Through its focus on functional snacks and nutritional supplements, Minayo provides options that cater to health-conscious individuals seeking to improve their overall well-being.
Adlai Nortye
Series D in 2021
Adlai Nortye Biopharma Co., Ltd. is a clinical-stage biopharmaceutical company specializing in the research and development of innovative cancer therapies and treatments for metabolic diseases. Founded in 2004 and based in Hangzhou, China, the company has established research and development and clinical operations in both China and the United States. Adlai Nortye has a diverse pipeline of over ten drug candidates, including several in various stages of clinical development, such as buparlisib (AN2025), palupiprant (AN0025), and AN4005, alongside preclinical candidates like AN8025, AN9025, and AN1025. The company emphasizes collaborations and internal discoveries to advance its strategic focus on oncology.
Huihe Medical
Series B in 2021
medical
Huihe Healthcare
Series B in 2021
Huihe Healthcare, founded in 2019 and based in Shanghai, China, focuses on the development and research of medical devices aimed at treating structural heart disease. The company is dedicated to creating innovative solutions for heart conditions, including a tricuspid valve repair system. By concentrating on intervention medical devices, Huihe Healthcare seeks to provide effective treatments for patients suffering from various heart diseases.
HiFiBiO
Series D in 2021
HiFiBiO is a biotherapeutics company that mobilizes the human immune system to combat disease. It commercializes proprietary single-cell technologies for applications in drug and biomarker discovery and development. It also aspires to benefit patients through open-innovation partnerships with industry and academia. HiFiBiO integrates deep-rooted biological expertise with its comprehensive single-cell profiling technologies to discover and accelerate a pipeline of antibody drugs to treat cancer and autoimmune disorders. The company was founded in 2013 and is headquartered in Paris, Ille-de-France.
Oriental Space
Angel Round in 2021
Oriental Space is an aerospace company that manufactures large solid rockets.
Django Robotics
Seed Round in 2021
django Robotics specializes in developing robotic solutions tailored for various industries, including e-commerce, footwear, apparel, beauty, healthcare, manufacturing, and third-party logistics. The company focuses on creating Autonomous Mobile Robots (AMRs) designed to enhance warehouse operations by autonomously navigating routes, thereby improving efficiency and productivity. Customers can reach out to django Robotics for inquiries via phone, email, and online applications, ensuring accessible support for their robotic needs.
Zonsen Peplib Biotech
Series A in 2021
Zonsen Peplib Biotech builds a peptide compound library and provides peptide drug discovery and development services for global pharmaceutical and biotech companies. The company's technology could compress the amino acid sequence information of about 500,000,000 peptides into 80,000 peptide compounds.
Oat Planet
Seed Round in 2021
Oat Planet is a healthy plant-based beverages company.
Jixin Communication
Series A in 2021
Jixin Communication specialized in delivering core solutions for open communication chips. It provides 5G core chip in the field of wireless communication, which greatly reduces the cost of 5G base station products.
CotheraBio
Venture Round in 2021
CotheraBio develops innovative cancer therapies with a focus on translational oncology. It has developed its proprietary i-CR® technology platform, which is a powerful method for providing individualized drug screening and new drug development. The platform combines a high content screening system with the conditional reprogramming of primary cultured tumor cells, which enables the efficient and undifferentiated expansion of primary patient-derived tumor cells in vitro, while also preserving the tumor’s heterogeneity.
Reforgene Medicine
Series A in 2020
Reforgene Medicine is a biomedical company focused on developing innovative drugs aimed at curing genetic diseases, chronic diseases, and cancer. Utilizing advanced gene editing and genomic technologies, the company works on creating programmable medicine that enhances treatment options for patients. By leveraging these cutting-edge techniques, Reforgene Medicine strives to improve patient outcomes and provide effective solutions for complex health challenges.
Credit Life
Series A in 2020
CreditLife is a technology enterprise dedicated to enhancing the operations of regional retail banks through a comprehensive digital platform. The company has developed a new generation of customer management systems that include essential tools for marketing, risk management, customer operations, and value realization. These systems are designed to assist small and medium-sized banks in acquiring customers, managing credit risks, and improving user interactions. By providing these integrated solutions, CreditLife empowers banks to refine their operational capabilities in the credit card and consumer credit sectors, ultimately fostering productivity growth and enabling them to compete more effectively in the financial services market.
Merico
Series A in 2020
Merico Inc. is a technology company that specializes in code contribution analytics, offering a platform designed to help software companies track and analyze their code repositories. Founded in 2018 and headquartered in San Francisco, California, Merico serves executives, management, and developers by utilizing advanced program analysis and machine learning. The company's solutions enable engineering teams to gain insights into productivity and code quality, facilitating better resource allocation and enhanced team performance. Through its innovative analytics technology, Merico aims to support organizations in optimizing their software development processes and improving overall efficiency.
Merico
Seed Round in 2020
Merico Inc. is a technology company that specializes in code contribution analytics, offering a platform designed to help software companies track and analyze their code repositories. Founded in 2018 and headquartered in San Francisco, California, Merico serves executives, management, and developers by utilizing advanced program analysis and machine learning. The company's solutions enable engineering teams to gain insights into productivity and code quality, facilitating better resource allocation and enhanced team performance. Through its innovative analytics technology, Merico aims to support organizations in optimizing their software development processes and improving overall efficiency.
Rgenta Therapeutics
Seed Round in 2020
Rgenta Therapeutics, Inc. is a biopharmaceutical company based in Cambridge, Massachusetts, specializing in the development of RNA-targeting medicines with a primary focus on oncology and neurological disorders. Founded in 2018, the company utilizes a proprietary platform that analyzes extensive genomic data to identify targetable RNA processing events. This platform enables the design of small-molecule compounds that modulate interactions among the spliceosome, regulatory proteins, and RNAs. By unlocking the therapeutic potential of previously undruggable targets, Rgenta aims to create oral, small-molecule therapies that address critical needs in human disease treatment, particularly in the realm of cancer.
Enjoy Move Tech
Angel Round in 2020
Enjoy Move Tech specializes in the research and development of high-performance computing software platforms tailored for smart cars and autonomous driving applications. The company focuses on creating intelligent driving application operating systems and artificial intelligence technologies that facilitate the integration of advanced driving solutions in vehicles. Central to its offerings is the self-developed EMOS middleware platform, which provides deterministic communication and scheduling capabilities. This platform has achieved TÜV Rheinland's ASIL D certification, ensuring high safety standards. Additionally, Enjoy Move Tech has developed a full-stack low-speed automatic driving algorithm known as the EM-Parking System, designed to operate effectively in various complex scenarios. The company's intelligent driving software and domain control solutions have reached mass production, reinforcing its position in the automotive technology sector.
Berxel
Series A in 2020
Shenzhen Berxel Technology Co., Ltd is a company that specializes in developing semiconductor chips for optoelectronic devices. Founded in 2018 and based in Shenzhen, China, Berxel focuses on the design, research and development, and sales of semiconductor and laser chips, along with various optoelectronic devices and accessories. The company is particularly noted for its vertical-cavity surface-emitting laser (VCSEL) technology, which enhances the efficiency of 3D sensor applications and supports ultra-low-power solutions for smart home devices, augmented reality, and virtual reality technologies.
Exegenesis Bio
Seed Round in 2019
Exegenesis is going to develop new medicine based on gene therapy and focuses on China and the global market. The team consists of experienced professionals, including gene therapy drug design, preclinical studies and clinical development.
Changmugu Medical
Seed Round in 2019
Beijing Changmugu Medical Technology Co., Ltd. is a healthcare startup specializing in artificial intelligence-powered solutions for orthopedic surgery. The company focuses on enhancing the accuracy and safety of surgical procedures through advanced technologies, including AI-assisted diagnosis and individualized operation plans. Additionally, it offers 3D printing patient-specific instrumentation (PSI) for surgical navigation and post-operative intelligent evaluation services. By leveraging AI deep learning, Changmugu Medical aims to provide innovative tools that improve patient outcomes and streamline surgical processes, ultimately contributing to safer and more stable operations in the field of orthopedics.
Qihan Biotech
Series A in 2019
Qihan Biotech is a biomedical company specializing in genetic technology with a focus on xenotransplantation. The company aims to address the critical shortage of organ donors by utilizing advanced gene editing techniques to develop safe and effective cells, tissues, and organs for human transplantation. Their mission is to eliminate the waiting period associated with organ transplants, providing patients with access to life-saving organs. By harnessing cutting-edge genetic editing technology, Qihan Biotech seeks to create viable organs that can be transplanted into humans, thereby contributing to a solution for the global organ donor crisis.
iGeneTech
Series B in 2019
iGeneTech is a private company based in Beijing, China, specializing in genetic testing solutions. Located in the Zhongguancun Life Science Park, it focuses on the research and development of high-throughput sequencing technologies, particularly targeted capture techniques. The company designs, manufactures, and tests genetic testing products, providing services primarily to clinical examinations and hospitals. Utilizing advanced technologies such as liquid crystal probe capture and multiplex PCR amplification, iGeneTech offers a range of products including gene capture reagents, kits, and synthetic biology solutions. This positions the firm as a key player in the genetic testing field, supporting advancements in medical diagnostics and research.
HiFiBiO
Series C in 2019
HiFiBiO is a biotherapeutics company that mobilizes the human immune system to combat disease. It commercializes proprietary single-cell technologies for applications in drug and biomarker discovery and development. It also aspires to benefit patients through open-innovation partnerships with industry and academia. HiFiBiO integrates deep-rooted biological expertise with its comprehensive single-cell profiling technologies to discover and accelerate a pipeline of antibody drugs to treat cancer and autoimmune disorders. The company was founded in 2013 and is headquartered in Paris, Ille-de-France.
DOCTOR U
Venture Round in 2019
DOCTOR U specializes in providing health care services.
Chuman
Series B in 2019
Chuman is a UGC Pan-Secondary Creation Community, providing creative platforms and studios for comic creators, and providing IP incubation and resource docking services. Users can quickly generate a lot of content through third-party or official materials, and can make friends, transactions and other activities within the community through the creation, while the APP also supports the dialogue novel reading function.
Vulinsight
Angel Round in 2019
Vulinsight is a Beijing-based company founded in 2012 that specializes in information security software solutions. The firm focuses on vulnerability management, offering services such as data asset management, data vulnerability management, and vulnerability lifecycle management. Vulinsight's platform enhances situational awareness regarding security vulnerabilities, facilitates security testing, and supports risk assessment. By integrating vulnerability resources, the company aims to provide efficient and precise control across various platforms, organizations, and processes, thereby addressing the complexities of managing security vulnerabilities.
Nuohui Medical
Series A in 2019
Nuohui Medical, established in November 2018 and based in Shanghai, specializes in medical payment and insurance solutions. The company focuses on providing payment options, reimbursement services, and insurance solutions tailored to commercial health insurance programs. It also offers medication authentication services to enhance patient support. By aiming to reduce out-of-pocket expenses for patients, Nuohui Medical seeks to improve the accessibility and adherence to necessary medications, particularly for major disease treatments.
Moyunsec.com
Series A in 2019
Beijing Moyunsec Technology Co., Ltd. specializes in active security verification and early-warning analysis software aimed at enhancing cybersecurity. Founded in 2017, the company integrates network attack techniques with machine learning to simulate hacker intrusions, allowing for proactive security measures. It offers a range of products, including the vackbot virtual hacker robot, MyScan risk detection system, and Qianxun Intelligence System. Additionally, Moyunsec provides services such as penetration testing, code auditing, and blockchain security. The company focuses on delivering continuous security verification and situational awareness for various sectors, including mobile Internet, Internet of Vehicles, and the Internet of Things, ensuring that data vulnerabilities are addressed before they can be exploited by hackers. Based in China, Moyunsec is committed to enhancing cybersecurity through innovative solutions and services.
Singulato Motors
Corporate Round in 2019
Singulato Motors is an electric vehicle start-up focused on developing new energy vehicles and innovative smart car systems. The company specializes in the research and design of various smart vehicles, including intelligent electric SUVs, multi-purpose vehicles, and mini smart cars, which feature advanced technologies such as anti-fatigue auto-driving mechanisms and night vision systems. Comprising a diverse team of experts from the Internet, automotive engineering, and intelligent hardware sectors, Singulato Motors aims to revolutionize the automotive industry through cross-border innovation and the integration of big data and cloud computing solutions. Its mission is to enhance driving safety and enjoyment while positioning itself as a leader in the new mobile Internet and intelligent vehicle market.
VIEWINTECH
Angel Round in 2019
VIEWINTECH specializes in developing network security products focused on detecting and protecting enterprise users from malware. The company's offerings include a cyber security solution that utilizes AI-assisted technology to detect and analyze encrypted traffic for potential cyber threats. This technology supports various sectors, including government and financial enterprises, in identifying and mitigating risks associated with encrypted communications.
Orvibo
Series C in 2019
Orvibo is a Chinese technology company specializing in Internet-of-Things (IoT) solutions and intelligent home hardware. The company develops a range of products, including micro intelligent devices for individual consumers and larger systems for villas, utilizing ZigBee wireless technologies. Its offerings also encompass full-digital visual doorbells based on TCP/IP technologies and cloud platforms, which support intelligent services for numerous IoT devices. Orvibo collaborates with various chip manufacturers to deliver comprehensive IoT solutions tailored for household appliances, LED lighting, security systems, and furniture. The organization is staffed by a diverse team of professionals, including software and hardware engineers, structural engineers, UI designers, solution engineers, and industrial designers. In addition to product development, Orvibo's research and development efforts focus on smart home technologies, home automation, and environmental control systems, positioning the company to meet the growing demand for integrated smart solutions in residential and commercial settings.
StarSee
Angel Round in 2019
StarSee is a technology company that specializes in developing artificial intelligence solutions for military and defense applications. Founded in 2018 and based in Nanjing, China, the company provides advanced big data information collection and analysis technologies tailored for military and police use. StarSee's products are designed to extract information from complex and unstructured data, thereby enhancing military intelligence and facilitating informed decision-making. With a focus on empowering military operations through innovative technology, StarSee aims to build comprehensive intelligence application systems that support various military functions.
Manyoujing
Seed Round in 2019
Manyoujing operates a marketplace platform focused on the used book trading sector in China. The platform enables users to recycle their idle books, facilitating the exchange for new books or other second-hand titles. This service not only promotes sustainability by reducing waste but also provides an economical option for readers to obtain literature across various categories, including fiction, travel, and technology. Recently, Manyoujing has secured initial funding, which will support its growth and expansion within the second-hand book market.
LenoMed Medical
Series C in 2019
LenoMed Medical is a manufacturer of medical devices focused on improving diabetes management. With over 15 years of research and development experience in infusion technology, the company specializes in creating innovative products such as the InnoTech insulin pump, drug infusion pumps, and related disposables. LenoMed is dedicated to enhancing diabetes care through the integration of continuous glucose monitoring technology with their insulin pumps, aiming to provide patients with better treatment options and monitoring capabilities. Their commitment to advancing diabetes management is reflected in their comprehensive diabetes care management system.
24Kick
Seed Round in 2019
24Kick is a provider of martial arts training services, operating multiple gymnasiums that offer a variety of courses, including boxing and jujitsu, catering to both adults and children. The company emphasizes an accessible training environment with 24-hour gym access, ensuring users can train at their convenience. Additionally, 24Kick features a fresh air system and independent health services, enhancing the overall training experience for its clients. Through its comprehensive offerings, the company aims to facilitate effective martial arts learning and personal development.
New Cloud Medical
Series A in 2019
New Cloud Medical is a prominent telemedicine platform specializing in the diagnosis and treatment of chronic pain. Founded in 2016 and based in Beijing, China, the company leverages a national network of key pain specialists and collaborates with the Sino-Japanese Hospital Pain Specialist Medical Association to enhance pain management practices. It constructs a tiered cloud platform for pain clinics across various administrative levels, including national, provincial, municipal, and county facilities. By integrating advanced medical technologies and a comprehensive database that utilizes extensive patient monitoring data, New Cloud Medical provides targeted pain management solutions. The company aims to elevate the standard of care in pain treatment through the establishment of specialized departments in public hospitals, ultimately creating a robust and professional consultation network and a sustainable operational model dedicated to addressing chronic pain.
Babel Novel
Series A in 2019
Babel Novel is a novel reading site that features stories in different genres. The company's app serves as a personal library for its users. Babel Novel also features novels in a different language.
Chaoneng Xiaohei
Series A in 2019
Chaoneng Xiaohei is a pet fresh grain e-commerce provider that provides pets with fresh meat and vegetables, zero additives, and dog food with a shelf life of 10 days.
eBrain
Seed Round in 2019
eBrain is an artificial intelligence application developer.
Berxel
Series A in 2019
Shenzhen Berxel Technology Co., Ltd is a company that specializes in developing semiconductor chips for optoelectronic devices. Founded in 2018 and based in Shenzhen, China, Berxel focuses on the design, research and development, and sales of semiconductor and laser chips, along with various optoelectronic devices and accessories. The company is particularly noted for its vertical-cavity surface-emitting laser (VCSEL) technology, which enhances the efficiency of 3D sensor applications and supports ultra-low-power solutions for smart home devices, augmented reality, and virtual reality technologies.
Boluo Banma
Series A in 2018
Boluo Banma is a home decor business that specializes in a diverse range of products, including posters, paintings, artwork, pillows, mattresses, quilts, lumbar support, seat cushions, and warm belts. The company curates collections from exceptional artists and studios worldwide, offering trendy and unique decorative items. In addition to enhancing aesthetic appeal, Boluo Banma's products are designed to address various comfort and health-related issues, providing solutions for customers looking to improve their living environments.
Adaps Photonics
Angel Round in 2018
Shenzhen Adaps Photonics Technologies Co., Ltd., founded in May 2018 by a group of four returned doctors, specializes in the development and manufacturing of advanced 3D sensor chips. Based in Nanshan, Shenzhen, with a research and development facility in Zhangjiang, Shanghai, the company employs over 80 professionals, including more than ten with doctorates from esteemed international universities. Adaps Photonics leverages single-photon detector technology to enhance smart hardware and three-dimensional perception capabilities across various applications. Its products are utilized in unmanned driving, communication equipment, security monitoring, smart home systems, mobile phone 3D modules, and lidar systems. This innovation enables downstream operators to create high-performance three-dimensional perception modules and depth sensing systems. The company gained recognition by winning first place in the electronic information category at the Shenzhen Peacock Team's 2019 China Entrepreneurship and Innovation Competition.
Data Grand
Series B in 2018
Data Grand specializes in text processing technology and intelligent office robot services, offering a range of solutions aimed at enhancing business efficiency across various industries. Their services include a text mining engine, intelligent recommendation systems, knowledge graphs, smart document reviews, and advanced search systems. Additionally, Data Grand provides tools for customer opinion insights, optical character recognition, and robotic process automation. By employing cutting-edge technologies such as natural language understanding and generation, the company enables users to efficiently extract, review, and search information from extensive databases. This focus on intelligent software systems helps enterprises improve their data mining capabilities while ensuring compliance and safety.
24Kick
Angel Round in 2018
24Kick is a provider of martial arts training services, operating multiple gymnasiums that offer a variety of courses, including boxing and jujitsu, catering to both adults and children. The company emphasizes an accessible training environment with 24-hour gym access, ensuring users can train at their convenience. Additionally, 24Kick features a fresh air system and independent health services, enhancing the overall training experience for its clients. Through its comprehensive offerings, the company aims to facilitate effective martial arts learning and personal development.
Maisi Math
Seed Round in 2018
Maisi Math is an education service provider that specializes in online mathematics classes. The company has developed a software as a service (SaaS) platform aimed at helping students aged 9 to 15 study mathematics more effectively. By offering small online classes, Maisi Math focuses on enhancing students' logical thinking, spatial imagination, and data analysis skills. Through its innovative approach, the platform seeks to make learning math engaging and efficient for young learners.
PharmCube
Series A in 2018
PharmCube operates as a comprehensive big data service platform tailored for the pharmaceutical industry. It offers data management, media information, and consulting services, facilitating access to critical real-time data. The platform establishes systematic drug data standards and employs extensive data mining techniques to connect various aspects of drug research and development, clinical trials, registration, access, sales, and investment. By providing these services, PharmCube enables pharmaceutical companies to enhance their development planning and market positioning through informed decision-making based on reliable data insights.
Beijing Haolang Technology
Angel Round in 2018
Beijing Haolang Technology uses inertial navigation and information fusion technology to solve the accuracy and real-time requirements.
Seengene
Series A in 2018
Seengene Inc. specializes in augmented reality (AR) technology, developing both software and hardware solutions that cater to various industries, including entertainment, retail, and security. Established in 2016 and based in Beijing, the company offers AR glasses and a cloud-based platform to enhance user experiences in settings such as museums, tourist attractions, and online shopping. Seengene's product offerings encompass customized AR solutions, software development kits (SDKs) for mobile devices, and untethered smart glasses. Additionally, the company has created a 3D visual information scanning device capable of efficiently capturing large indoor and outdoor spaces, which can then be used for reconstruction and localization. Seengene also collaborates with Peking University to address complex computer vision challenges that enhance mixed reality interactions. By leveraging its advanced AI technology, Seengene aims to improve operational efficiency and user engagement across cultural tourism, marketing, and industrial sectors.
Ehomepoct
Seed Round in 2018
Ehomepoct is a healthcare management company based in Changsha, China, specializing in the manufacture of diagnostic test kits. The company produces a range of products, including pregnancy tests, inflammation tests, and menstrual period tests, as well as early embryo testing. Ehomepoct also focuses on integrating artificial intelligence into medical treatment applications, enhancing rapid diagnosis and health management services.
Doc.ai
Seed Round in 2018
Doc.ai, Inc. is a company based in Palo Alto, California, focused on developing artificial intelligence technologies for the healthcare sector. Founded in 2016, it offers a medical research companion application that facilitates personal-omics data collection and digital health trials, allowing participants to earn financial rewards. The company's poly-omics data pipeline processes various types of medical data, enabling effective analysis and model building. In addition to its consumer offerings, Doc.ai licenses AI modules and creates tailored products for a diverse range of clients, including payors, pharmaceutical companies, healthcare providers, and patient organizations. Through its innovative platforms, Doc.ai aims to enhance medical research and transform healthcare delivery.
Yunding Technology
Series C in 2018
Yunding Network Technology is a developer of smart home security systems, specializing in smart locks in the smart apartment segment under its brands Loock and Yunding.
Changchang Kid's English
Seed Round in 2018
Changchang English is an education startup based in Shanghai that focuses on providing English language learning services for children aged 0-6. The company utilizes innovative teaching methods, including content-based instruction and total physical responses, to engage young learners and stimulate their interest in the language. By offering an interactive and immersive learning environment, Changchang English aims to provide children with early exposure to English, helping them build a solid foundation for future language acquisition.
MoonX
Angel Round in 2018
Shenzhen MoonX Technology Co., Ltd. is a company focused on developing software solutions for autonomous vehicles, particularly in the realm of driverless technology. Founded in 2018 and based in Shenzhen, China, MoonX specializes in precision mapping, positioning, sensing, controlling, and planning. The company leverages advanced technologies such as computer vision, LiDAR, and satellite positioning to enhance unmanned logistics services. Through its innovations, MoonX aims to provide enterprises with safer and more cost-effective transportation options for logistics and delivery applications.
HiFiBiO
Series B in 2018
HiFiBiO is a biotherapeutics company that mobilizes the human immune system to combat disease. It commercializes proprietary single-cell technologies for applications in drug and biomarker discovery and development. It also aspires to benefit patients through open-innovation partnerships with industry and academia. HiFiBiO integrates deep-rooted biological expertise with its comprehensive single-cell profiling technologies to discover and accelerate a pipeline of antibody drugs to treat cancer and autoimmune disorders. The company was founded in 2013 and is headquartered in Paris, Ille-de-France.
Young Beauty
Angel Round in 2018
Young Beauty engages in research, development, production, and sales of cosmetic ingredients, including industrial modules for plant extraction, enzyme fermentation, and chemical synthesis. They offer customized cosmetic services such as ingredient formulation.
CiDi
Series A in 2018
CiDi focuses on the technological innovation and execution required to create practical, self-driving commercial vehicles and products. The company has obtained public road testing permits for SAE Level 4 trucks capable of exceeding 100km/h on highways. During the first two years, the company completed numerous projects for various commercial and special vehicles. CiDi, for example, has delivered unmanned and remote-controlled mining trucks to mining areas for operation, as well as operated intelligent buses on open city streets and mass-produced V2X-connected vehicles and equipment in multiple cities and regions.
Pony.ai
Series A in 2018
Pony.ai, Inc. is a technology company specializing in autonomous driving solutions and artificial intelligence software for automated vehicle manufacturing. Founded in 2016 and headquartered in Fremont, California, with additional offices in San Francisco and China, Pony.ai develops systems that utilize machine learning to navigate vehicles across diverse driving conditions. The company's technology focuses on accurately perceiving the vehicle's environment and predicting driver actions to enhance safety and functionality. In addition to its core development efforts, Pony.ai also operates a public-facing Robotaxi service, showcasing its advancements in autonomous mobility. Through collaborations with automotive manufacturers, Pony.ai aims to integrate its innovative technology into commercial vehicles, significantly contributing to the evolution of transportation.
Panda Insurance
Series A in 2018
Automobile insurance sales management platform.
PANDAINS
Series A in 2018
PANDAINS is an automobile insurance platform.
bimart.cn
Angel Round in 2018
bimart.cn helps firms reduce costs, shorten confirmation times, improve the efficiency of confirmation, and increase the response rate to confirmation. It is a financial technology company that focuses on commercial credit pricing and circulation.
Moyunsec.com
Series A in 2017
Beijing Moyunsec Technology Co., Ltd. specializes in active security verification and early-warning analysis software aimed at enhancing cybersecurity. Founded in 2017, the company integrates network attack techniques with machine learning to simulate hacker intrusions, allowing for proactive security measures. It offers a range of products, including the vackbot virtual hacker robot, MyScan risk detection system, and Qianxun Intelligence System. Additionally, Moyunsec provides services such as penetration testing, code auditing, and blockchain security. The company focuses on delivering continuous security verification and situational awareness for various sectors, including mobile Internet, Internet of Vehicles, and the Internet of Things, ensuring that data vulnerabilities are addressed before they can be exploited by hackers. Based in China, Moyunsec is committed to enhancing cybersecurity through innovative solutions and services.
Chedaidai
Series A in 2017
Chedaidai is a Chinese auto financial services platform which mainly provides loan service for car buyers.
Chuman
Series A in 2017
Chuman is a UGC Pan-Secondary Creation Community, providing creative platforms and studios for comic creators, and providing IP incubation and resource docking services. Users can quickly generate a lot of content through third-party or official materials, and can make friends, transactions and other activities within the community through the creation, while the APP also supports the dialogue novel reading function.
Ri Geng Jihua
Series A in 2017
Ri Geng Jihua is an online comic-reading platform.
NewDoon
Series A in 2017
NewDoon is a research, development, and manufacturing company of life science products and solutions. It is a company that develops neuroscience products and solutions. They have developed wireless optogenetics systems, fiber photometry systems, and miniaturized fluorescence microscopy.
Ripcord
Series B in 2017
Ripcord, Inc. is a robotic digitization company that specializes in automating the management of paper records. Founded in 2014 and headquartered in Los Angeles, California, Ripcord develops a platform that utilizes advanced technologies, including artificial intelligence, machine learning, and vision-guided robotics, to create digital twins of physical documents. Its flagship solution, Canopy, captures, enriches, and organizes critical content, allowing enterprises to enhance their business processes with improved speed, quality, and accuracy. Formerly known as Ripcord Digital, Inc., the company rebranded in June 2017 to reflect its focus on innovative digitization solutions.
meigene.cn
Seed Round in 2017
meigene.cn is a genetic testing excellent service company.
On the Road Store
Series A in 2017
On the Road Store is a media e-commerce platform.
NewTank
Seed Round in 2017
NewTank is a business development company focused on facilitating business evolution. It offers a range of products and guidance aimed at transforming sales processes into more professional and service-oriented operations. Additionally, NewTank specializes in marketing and promotional services for financial institutions, providing solutions such as brand promotion, online customer marketing, and loyalty management. The company leverages high-tech solutions to enhance transaction efficiency and improve overall business performance.
Health Plus
Angel Round in 2017
Uplus Health is a service solution provider that uses Internet technology to intelligently connect medical care, insurance, and clients. It provides insurance companies and enterprises with professional and optimized marketing plan design, medical network, health service and cost risk control, and other menu services; it provides customers with intelligent medical guidance, VIP channels for medical treatment, advance payment of hospitalization expenses, and so on.
Qingzhi
Angel Round in 2017
Tianjin Qingzhi Technology Co., Ltd. is a Chinese company established in 2016 that specializes in the research, development, production, and sales of advanced driver-assistance systems and autonomous driving technology for unmanned vehicles. The company focuses on creating factory-installed solutions that include low-cost sensors, precision positioning perception, embedded controllers, and comprehensive electrical and electronic architectures. Additionally, Qingzhi provides remote monitoring and management systems to enhance the functionality and safety of autonomous vehicles.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.